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Lambda Red-mediated Recombineering in
the Attaching and Effacing Pathogen
Escherichia albertii
Marisa Egan1,2, Jasmine Ramirez1,5, Christian Xander1,6, Chirag Upreti3,4 and Shantanu Bhatt1*
Abstract
Background: The ability to introduce site-specific mutations in bacterial pathogens is essential towards understanding
their molecular mechanisms of pathogenicity. This has been greatly facilitated by the genetic engineering technique of
recombineering. In recombineering, linear double- or single-stranded DNA molecules with two terminal homology arms
are electroporated into hyperrecombinogenic bacteria that express a phage-encoded recombinase. The recombinase
catalyzes the replacement of the endogenous allele with the exogenous allele to generate selectable or screenable
recombinants. In particular, lambda red recombinase has been instrumental in engineering mutations to characterize
the virulence arsenal of the attaching and effacing (A/E) pathogens enteropathogenic Escherichia coli (EPEC),
enterohemorrhagic E. coli (EHEC), and Citrobacter rodentium. Escherichia albertii is another member of this taxon;
however, the virulence of E. albertii remains cryptic despite accumulating evidence that E. albertii is an emerging
pathogen. Multiple retrospective studies have reported that a substantial number of EPEC and EHEC isolates (~15 %)
that were previously incriminated in human outbreaks actually belong to the E. albertii lineage. Thus, there is
increased urgency to reliably identify and rapidly engineer mutations in E. albertii to systematically characterize
its virulence determinants. To the best of our knowledge not a single chromosomal gene has been altered by
targeted mutagenesis in E. albertii since it was first isolated almost 25 years ago. This is disconcerting because an
E. albertii outbreak could cause significant morbidity and mortality owing to our inadequate understanding of its
virulence program.
Results: In this report we describe a modified lambda red recombineering protocol to mutagenize E. albertii. As proof
of principle, we successfully deleted three distinct virulence-associated genetic loci – ler, grlRA, and hfq – and replaced
each wild type allele by a mutant allele with an encodable drug resistance cassette bracketed by FRT sites. Subsequently,
the FRT-site flanked drug resistance marker was evicted by FLP-dependent site-specific recombination to generate
excisants containing a solitary FRT site.
Conclusions: Our protocol will enable researchers to construct marked and unmarked genome-wide mutations in
E. albertii, which, in turn, will illuminate its molecular mechanisms of pathogenicity and aid in developing appropriate
preventative and therapeutic approaches to combat E. albertii outbreaks.
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Background
Whole genome sequencing has ushered in a new era that
has revolutionized the field of microbial genetics [1, 2].
Within the past decade sequencing has become more ro-
bust, inexpensive, and quick. A scientific sub-discipline
that has benefited immensely from rapid genome sequen-
cing is bacterial pathogenesis [3, 4]. The availability of
complete genome sequences has enabled bacteriologists
to undertake a global investigation of a pathogen’s
transcriptome [5–8], proteome [9–11], and metabolome
[12, 13] at an unprecedented level. However, the accu-
mulation of such large-scale genome-wide data has
left scientists with even more questions than answers
[1, 2]. For instance, in any sequenced microbial gen-
ome a substantial number of genes remain func-
tionally unannotated or classified as “putative” or
“hypothetical” [1, 2]. Similarly, transcriptomic, prote-
omic, and metabolomic studies, while highlighting the
number and nature of specific biomolecules expressed
under specific conditions, do not reveal their function
[1]. Thus, now, more than ever before, the tools and
techniques used in forward (starting from a biological
process and determining its genetic basis) and reverse
genetics (starting from a gene and determining the
biological process(es) controlled by it) will become
invaluable and essential towards understanding the
functions of genes on a genome-wide scale.
The single most important technique in the molecular
toolkit of a microbial geneticist is mutagenesis. Mutagenesis
enables a researcher to construct mutations – stable
changes in the nucleotide sequence of an organism that
are inheritable. Analysis of mutants, in turn, permits re-
searchers to characterize the environmental and regula-
tory controls of a gene [14, 15], deduce the structure-
function relationship of the gene product [16, 17], and
determine the regulon and range of biological processes
controlled by it [18–20]. Mutations can be classified on
the basis of the effect that they have on the expression
and/or activity of the gene product. The different kinds of
mutations include amorphic (complete loss in expres-
sion and/or activity of the gene product), hypomorphic
(reduced expression and/or activity), hypermorphic
(increased expression and/or activity), neomorphic (a novel
function or pattern of expression associated with the
gene product), and antimorphic (dominant negative)
mutations. To introduce such mutations in bacterial
genomes geneticists have developed a diverse range of
chemical, biological, and physical mutagens [1]. Some
of these mutagens such as base analogues, alkylating
agents, radiations, and transposable elements introduce
nonspecific and genome-wide random mutations [1, 2].
By contrast, the construction of gene-specific mutations
is primarily accomplished by the use of suicide vectors
[2, 21, 22] or recombineering [23–32].
A suicide vector is a plasmid that possesses certain key
characteristics: a conditional origin of replication that
enables the plasmid to replicate under permissive condi-
tions but not under non-permissive conditions, a select-
able maker, which confers a phenotypic benefit to the
bacterium under specific conditions (e.g. drug resistance
or prototrophy), a counterselectable marker, which pro-
motes bacterial death under certain conditions (e.g. an
enzyme that converts a pro-drug to a drug toxic to the
bacterium), and a polylinker region to facilitate cloning
[2, 21, 22, 33]. The desired mutant allele is inserted into
the polylinker region and the recombinant vector is
introduced into a suitable bacterial transcipient. The
transcipient is subsequently grown under conditions that
are not only non-permissive for plasmid replication but
also select for bacteria that stably express the plasmid-
encoded selectable trait. The mutant colonies that are
observed are merodiploid integrants, in which the plas-
mid encoded mutant allele has undergone homologous
recombination with the chromosomally encoded wild
type allele thereby inserting the entire plasmid into the
bacterial chromosome and facilitating the expression of
the selectable marker. Integrants can then be grown
under conditions where the counterselectable marker is
expressed to induce toxicity and promote bacterial
lethality. Any observed excisants are typically those in
which the counterselectable marker, along with the
plasmid backbone, has been successfully evicted. This
occurs by a second recombinational event between the
wild type and mutant allele, which either restores the
original wild type allele or replaces it with the mutant
allele [2, 21, 22]. Suicide vectors can be used to intro-
duce a gamut of precise chromosomal modifications in
different bacteria [34–38]. However, in today’s day and
age of genetic engineering the reliance on suicide vectors
to introduce gene-specific mutations has diminished
substantially. This is because this technique is cumber-
some, requires prior cloning of the mutant allele onto
the suicide vector, is limited by the presence of restric-
tion sites on the plasmid, prone to illegitimate recombi-
national events, and logistically may span several days.
Within the past decade the revolutionary technique
of recombineering has largely replaced the use of
suicide vectors to construct locus specific mutations
[23, 25–28, 31, 32, 39–41]. Recombineering circumvents
the need to rely on restriction enzymes, DNA ligases, and
cloning into suicide vectors for allelic replacement. Re-
combineering, a portmanteau for recombination-mediated
genetic engineering, is a technique for manipulating the
bacterial genome in vivo by using phage-encoded recom-
binases [31]. The most frequently employed recombinases
include the Rac prophage-encode RecET [32, 42–44] and
the lambda prophage-encoded Red [23–28, 31, 41]. Bac-
teria that express RecET or lambda Red proteins are
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rendered hyperrecombinogenic and are capable of
catalyzing efficient homologous recombination between
linear single-stranded (ss) or double-stranded (ds)
DNA molecules with two short terminal arms that
share ~40–50 nucleotides of homology to a target
DNA [23–26, 32, 40, 45]. The RecET system consists of
two proteins – RecE and RecT [32]. RecE is a ds specific
DNA exonuclease that sequentially degrades the 5′ end of
DNA to generate single stranded (ss) 3′ overhangs [42].
RecT, in turn, binds to the ssDNA and facilitates base
pairing between the two homology arms and complemen-
tary sequences on the target DNA resulting in homolo-
gous recombination and the eventual replacement of
the chromosomal allele with the mutant allele [32, 44].
The lambda Red recombination system includes three
proteins – Exo, Beta, and Gam [23, 26, 27, 31, 41]. Exo,
like RecE, is a 5′→3′ dsDNA specific exonuclease that
generates a ssDNA intermediate [39, 46]. Beta, like
RecT, binds to the ssDNA intermediate and base pairs
it to its complementary single stranded target to form a
heteroduplex and facilitate homologous recombination
[47, 48]. An accessory component of the lambda red sys-
tem is Gam. Gam inhibits the RecBCD and SbcCD nucle-
ases thereby preventing the degradation of dsDNA to
enhance recombination [49, 50]. When linear dsDNA is
used as a substrate then both the exonuclease (RecE/Exo)
as well as the ssDNA binding protein (RecT/Bet) are
necessary for recombineering [29, 51]. By contrast, when
ssDNA/oligonucleotides are used, then the ssDNA aneal-
ing protein is sufficient for homologous recombination
[40, 52, 53]. Furthermore, recombination frequencies are
orders of magnitude higher using ssDNA compared to
dsDNA [29].
The lambda Red recombineering system, in particular,
has transformed our understanding of the molecular
mechanisms of bacterial pathogenicity in a wide range of
Gram-negative pathogens including several members of
the attaching and effacing (A/E) family of pathogens, which
encompasses enteropathogenic Escherichia coli (EPEC),
enterohemorrhagic E. coli (EHEC), Citrobacter rodentium,
and Escherichia albertii [14, 15, 25, 35, 37, 54]. A/E patho-
gens are classified as such because upon infection the bac-
terium depolymerizes actin filaments, thereby destroying
the structural and functional integrity of the intestinal
microvilli (effacement) [14, 15, 55, 56]. Thereafter, the
depolymerized actin is recruited beneath the adherent bac-
terium and repolymerized to form actin-filled membrane-
enclosed evaginations called pedestals that are capped by
the infecting bacterium (attachment) [14, 15, 56, 57]. The
overall pathological manifestation of attachment and ef-
facement is the diminished ability of enterocytes to absorb
water and nutrients, which leads to diarrhea [14, 15].
The pathogenicity island locus of enterocyte effacement
(LEE) is essential for pedestal formation [14, 15, 58–61].
The LEE encodes a functional type 3-secretion system
(T3SS) that punctures the host cell membrane and allows
A/E pathogens to inject a range of effector molecules
directly into the infected cell [37, 62–69]. These effector
molecules are involved in the subversion of host signal
transduction and regulatory pathways, which lead to the
observed ultrastructural changes including microvillar
disintegration and pedestal formation – diagnostic hall-
marks of infection by the A/E pathogens [14, 15]. Thus,
understanding the regulation of the LEE is imperative to
develop efficacious prophylactic and/or therapeutic mea-
sures. Between EPEC and EHEC virtually every conceiv-
able mutation – point, substitutions, insertions, deletions,
epitope tagging, and marked– has been engineered by
recombineering [25, 35, 70–72]. This constellation of mu-
tations has revealed an intricate regulatory landscape that
fine-tunes gene expression from the LEE in response to
diverse environmental stimuli [14, 15, 73]. Moreover,
recombineered EPEC and EHEC mutants have also
yielded mechanistic insight into several trans-acting fac-
tors and cis-acting elements [14, 15, 74]. Similarly, in the
murine pathogen Citrobacter rodentium recombineering
was used, in part, to systematically mutate every gene that
is encoded within the LEE to elucidate the genetic control
of pathogenesis [37]. This study was groundbreaking in
that the researchers identified two novel LEE-encoded
regulators, GrlR and GrlA, that repress and activate the
LEE respectively [37]. Besides GrlR and GrlA, the LEE also
encodes the master transcriptional regulator, Ler [75, 76].
Ler, GrlR, and GrlA are conserved between Citrobacter
rodentium, EPEC, and EHEC [14, 15, 37, 73, 75, 76]. These
transcription factors are indispensible for the synchronized
spatiotemporal regulation of genes expression from the
LEE, which climaxes with pedestal morphogenesis and the
accompanying virulence of A/E pathogens [14, 15].
Intriguingly, even though the lambda red proteins are
operational in A/E pathogens, induction of a hyperrecom-
binogenic state depends upon the vector that expresses
these genes. For instance, Murphy and Campellone ob-
served that EHEC recombinants are readily obtainable
only when the lambda red genes were expressed from the
low-copy plasmids pKM201 or pKM208 but not when the
expression platform was the high-copy plasmid pTP223
[25]. Reciprocally, in EPEC, recombinants were only ob-
served when the lambda red proteins were expressed from
pTP223 [25]. Similar observations have also been reported
in E. coli [23]. Thus, the expression of lambda red proteins
from a suitable vector is instrumental in engineering de-
fined mutations in bacteria.
Whereas recombineering has been effectively utilized to
understand the molecular pathogenesis of EPEC, EHEC,
and Citrobacter rodentium, it has, thus far, not been
adapted for Escherichia albertii [25, 35, 37, 54, 77, 78].
E. albertii was first isolated from diarrheal stool
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samples of five children from Bangladesh by John
Albert and his collaborators at the International Centre
for Diarrheal Disease Research, Bangladesh (ICDDR-B)
in the early 1990s [79]. The children were febrile, pre-
senting with watery diarrhea, dehydration, vomiting,
and abdominal distension. Initially, these isolates were
classified as Hafnia alvei [79]. However, Albert et al.
subsequently discovered that these isolates possessed
the eae gene, which is normally present in A/E patho-
gens but absent in H. alvei. eae codes for intimin – an
outer membrane protein essential for pedestal forma-
tion by A/E pathogens [80]. Moreover, a comparison of
the 16S rRNA sequence of these strains with eae-nega-
tive H. alvei isolates revealed a low degree of sequence
similarity, thereby warranting their taxonomic reclassi-
fication [81]. Subsequent attempts to accurately re-
classify these diarrheal isolates also yielded ambiguous
results [82]. The same isolates yielded highly variable
phenotypic and biochemical profiles characteristic of
Yersinia ruckeri, Salmonella enterica, H. alvei, EHEC,
and Citrobacter depending upon the commercial diag-
nostic kit used for taxonomic classification [82]. More
recently though, using a battery of conventional bio-
chemical and phenotypic assays, 16S rRNA sequencing,
DNA-DNA hybridization, and allele-specific PCR these
isolates were unambiguously shown to be distantly
related to the Escherichia (55–64 %) and Shigella
(54–60 %) genera and have been defined as a novel
Escherichia species, Escherichia albertii [82, 83]. Still, very
little is known about this diarrheal pathogen today, so its
misidentification persists. A recent retrospective study re-
examined 179 clinical strains that were originally isolated
from diseased humans and animals and had been classi-
fied as EPEC or EHEC on the basis of routine diagnostic
assays. Multilocus sequencing of these strains revealed
that of these strains, 26 (14.5 %) were actually E. albertii
isolates that had been incorrectly assigned to the EPEC or
EHEC taxa [84]. Similarly, EPEC was implicated as the
etiologic agent for a foodborne outbreak in Fukuoka and
Kumamoto cities of Japan in 2003 and 2011 respectively.
However, reexamination of these strains by PCR and
additional biochemical assays confirmed them to belong
to the E. albertii lineage [85, 86]. In another recent study
an E. albertii strain possessing the stx2a allele was isolated
from a patient who suffered from bloody diarrhea in
Norway [87]. Shiga toxin 2a (Stx2a) is one of the most po-
tent isoforms of the Shiga toxin that has been implicated
in hemorrhagic colitis and the life-threatening complica-
tion hemolytic uremic syndrome (HUS) [88–91]. Prior to
this report, only the stx2f allele, which produces mild
symptoms and has no prior link to bloody diarrhea or
HUS, was reportedly observed in a subset of E. albertii
strains [84, 87]. In the genus Escherichia stx2a is most
frequently associated with EHEC [92], and to a lesser
degree with enteroaggregative E. coli (EAEC) [93]. This
presence of this allelic variant has often been used as a re-
liable marker to narrow down the Escherichia isolate to
these pathotypes. However, the presence of stx2a in E.
albertii suggests that some of stx2a possessing E. coli
strains that are currently designated as EHEC or EAEC
may actually be E. albertii. Moreover, this genotypic fea-
ture accentuates the virulence potential of E. albertii.
Clearly, there is increased urgency to reliably diagnose E.
albertii isolates and rapidly identify and characterize the
repertoire of its virulence determinants, determine their
mode of action, and the virulence-associated processes
controlled by them – a formidable task that requires the
engineering of specific and random E. albertii mutants.
While the genome of E. albertii has been sequenced,
to the best of our knowledge, we have not encountered
any reports demonstrating chromosomal modifications
in E. albertii. Here we describe a simple modified pro-
tocol using the lambda Red recombineering system to
generate chromosomal mutations in E. albertii, which
appears to be genetically recalcitrant. Using this protocol
we successfully deleted the LEE-encoded genes, ler and
grlRA, and the non-LEE encoded gene hfq, albeit at
frequencies lower than those reported in E. coli. This
protocol will aid pathogeneticists to rapidly construct
knockout, knockin, epitope-tagged, transcriptional, trans-
lational, and other subtle mutations in E. albertii in order
to comprehensively characterize its molecular mecha-
nisms of virulence to successfully counteract this emer-
ging broad host pathogen.
Results and Discussion
Our initial attempts at recombineering in E. albertii using
pKD46 were largely unsuccessful or non-reproducible
(data not shown). Previous research has shown that
recombineering efficiency is significantly enhanced in the
related bacterium E. coli when the lambda red genes are
expressed from the pSIM rather than the pKD family of
plasmids [28]. The pSIM family of plasmids is derived
from the defective lambda prophage in which the minimal
lambda red recombinase operon, consisting of the genes
gam, bet, and exo, is expressed from the pL promoter
under the transcriptional control of the thermolabile
CI857 lambda repressor [28]. At low temperatures ranging
from 30–34 °C CI857 is active and binds to the operator
site thereby sterically hindering the promoter and pre-
venting transcription. A thermal upshift to 42 °C revers-
ibly denatures the CI857 repressor thereby inactivating it
and leading to the derepression of the gam, bet, and exo
genes thereby inducing a temporary hyperrecombinogenic
state in the bacterium [28]. When such a bacterium is
transformed with dsDNA or oligonucleotides that possess
two terminal arms of ~40–50 nucleotides of homology to
a target gene the lambda red recombinase promotes the
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replacement of the endogenous allele with the exogenous
allele. Transcription from pL promoter can be shut off by
transferring the cultures back to 30 °C at which the CI857
repressor renatures and binds to the operator to prevent
further transcription. Reversible repression by CI857 pre-
vents the unregulated expression of the lambda red genes,
which has previously been shown to be mutagenic [25].
Induction of the lambda red genes for as little as
15 min generates a large number of recombinants in E.
coli. We used conditions similar to those previously de-
scribed for E. coli to engineer hyperrecombinogenicity in
E. albertii. LS5504 (E. albertii strain Albert 19982T
transformed with pSIM6) was thermally induced for 7.5,
15, or 30 min at 42 °C and subsequently made electro-
competent. Electrocompetent cells were then trans-
formed with 1.5 μg of Δler::cat amplicon at 1.8 kV. After
overnight recovery cultures were spread on LB plates
supplemented with chloramphenicol (3.125 μg/ml) and
screened to identify CmR recombinants. No recom-
binants were obtained under these experimental condi-
tions. Interestingly, when the electroporation voltage
was increased to 2.5 kV, a reproducible increase in
recombineering was observed with ~14.0 ± 1.3 recombi-
nants per 1010 cfu per μg of DNA. Recombinants were
observed at chloramphenicol concentrations as high as
6.25 μg/ml (data not shown). At higher concentrations
(12.5–25 μg/ml) no recombinants were observed. Inter-
estingly, the higher concentrations correspond to the se-
lective conditions typically used by us to isolate
recombinants of EPEC and E. coli (data not shown).
Thereafter, we proceeded to vary other experimental pa-
rameters to further enhance recombineering efficiency.
We reasoned that prolonged expression of the lambda
red genes could further increase recombineering. Con-
sistent with this prediction induction of the red operon
for an hour at 42 °C followed by electroporation at
2.5 kV further increased the recombination frequency
by ~3.3-fold (46.2 ± 7.3 recombinants per 1010 CFU per
μg of DNA). From one such experiment 12 CmR mutants
were screened by locus specific PCR to verify that the
CmR phenotype stemmed from the allelic replacement of
ler+ with the Δler::cat allele (Fig. 1a). Of the 12 isolates
screened, 11 had successfully replaced the wild type allele
with the mutant allele (Fig. 1a). pSIM6 was cured from
the recombinants by culturing them at 42 °C.
We then proceeded to test the feasibility of evicting
the cat cassette that is bracketed by direct repetitive
FRT sites. Two such Δler::cat mutants (LS5568 &
LS5570) were transformed with the plasmid pFT-K,
which expresses FLP recombinase under the control of
the TetR repressor, to generate LS5592 and LS5593 re-
spectively. Unautoclaved chlorotetracycline was added at
a range of concentrations (20–200 μg/ml) to inactivate
TetR to derepress FLP recombinase. FLP recombinase
catalyzes the site-specific recombination between the
two FRT sites to evict the cat cassette and generate exci-
sants that are phenotypically CmS and contain a single
FRT site. It was observed that the excision frequency
decreased precipitously as the concentration of chlorote-
tracycline increased (Fig. 1b). At a chlorotetracycline
concentration of 20 μg/ml ~90 % of the observed col-
onies had evicted the cat cassette, whereas at 200 μg/ml
the eviction frequency was reduced to ~15 % (Fig. 1b).
This was unexpected because we anticipated that in-
creasing the chlorotetracycline concentration would lead
to higher expressivity of flp and enhance excision fre-
quency. However, we did observe that as the chlorotetra-
cycline concentration was increased the total CFU count
decreased substantially (data not shown). Perhaps, the
slowed growth rate may detrimentally affect the expres-
sion and/or activity of the FLP recombinase enzyme.
CmS excisants were also verified by locus specific PCR
to confirm that the sensitivity to the antibiotic correlated
with the loss of the cat cassette and the presence of the
Δler::FRT allele (Fig. 1c). pFT-K was successfully cured
from the excisants by incubating them at 42 °C over-
night and screening for KanS isolates (data not shown).
The usefulness of lambda red recombineering arises
from the fact that it can be utilized to engineer a pleth-
ora of mutations at virtually any genetic loci in a range
of bacteria [23–26, 37]. Therefore, we next determined if
recombineering was equally versatile in E. albertii. To
address this we attempted to mutate the grlRA operon,
located within the LEE, and the hfq gene, located outside
the LEE. The LEE-encoded grlRA locus specifies the two
transcription factors GrlR and GrlA that exhibit con-
served synteny in all the A/E pathogens including E.
albertii [37, 94–97]. GrlR and GrlA synchronize gene
expression from the LEE that culminates with pedestal
morphogenesis by EPEC, EHEC, and Citrobacter roden-
tium [14, 15, 37, 70, 98]. Meanwhile, Hfq functions as an
RNA chaperone that facilitates base-pairing between
sRNAs and their target mRNAs to affect RNA stability
and/or translation [99, 100]. Hfq has a prominent role in
controlling the LEE in EPEC and EHEC [18, 19, 94]
(Bhatt S. Unpublished observations). However, the roles of
grlR, grlA, and hfq remain unexplored in E. albertii. The
ΔgrlRA::kan and Δhfq::cat mutant alleles were synthesized
by PCR essentially as described above. The ΔgrlRA::kan
amplicon possesses two terminal homology arms of 50
nucleotides in length. The upstream arm is identical to
the region immediately upstream of the grlR ORF whereas
the downstream arm is identical to the 3′ end of the grlA
ORF (30 nucleotides) and 20 nucleotides downstream off
of it. Thus, upon successful recombineering, the entire
grlRA operon excluding the terminal 30 nucleotides of the
grlA ORF and its 3′ UTR are replaced by a kan cassette
bracketed by FRT sites. The ΔgrlRA::kan amplicon was
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electroporated into hyperrecombinogenic bacteria using
the optimized recombineering protocol. After recovering
the cultures overnight, aliquots were spread onto LB plates
supplemented with varying concentrations of kanamycin
(12.5–22.5 μg/ml) and screened for KanR recombinants.
Two types of colonial morphologies were readily apparent
on kanamycin plates: big sized colonies and punctiform
satellite colonies. We observed that at a concentration of
12.5 μg/ml comparable numbers of big colonies were ob-
served for both the transformed and untransformed con-
trol (data not shown). Some punctiform colonies were
also observed (<20 CFU). However, at higher kanamycin
concentrations (17.5–22.5 μg/ml) big colonies were ob-
served only in the case of the transformed cultures (17,
31, and 34 recombinants/μg of DNA on 17.5, 20, and
22.5 μg/ml of kanamycin respectively). Nonetheless, the
number of punctiform satellite colonies remained un-
changed (<20 CFU) at 17.5 and 20 μg/ml of kanamycin.
However, punctiform colonies were rarely observed at
22.5 μg/ml of kanamycin. Three big colonies were ran-
domly picked from the LB plates containing the two high-
est concentrations of kanamycin (20 and 22.5 μg/ml) and
screened by PCR to confirm allelic replacement (Fig. 2a).
Lanes 2–4 and 5–7 correspond to the PCR product ob-
tained from potential recombinants that arose on plates
containing 20 or 22.5 μg/ml of kanamycin respectively. All
the candidate KanR isolates had successfully replaced the
grlRA operon with the ΔgrlRA::kan allele (Fig. 2a, lanes 2–
7). Whereas Δler::cat and ΔgrlRA::kan recombinants were
readily obtained in E. albertii, recombination at the hfq
locus was relatively recalcitrant. No recombinants were
observed in our first attempt whereas in the 2nd attempt
only 1 CmR isolate was observed after incubating the
plates for 48 h. This isolate was confirmed to have
substituted hfq+ with the Δhfq::cat allele (Fig. 2b, lanes
2–3). Previous reports suggest that the hfq mutant in
ler+
Δler::cat
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Fig. 1 a Locus specific PCR to confirm the replacement of ler+ with Δler::cat allele in E. albertii by recombineering. Twelve colonies that arose on
chloramphenicol plates were screened by PCR, using a pair of primers, one of which bound upstream (SB2456) and the other downstream
(SB2457) relative to the recombination site, to confirm that the CmR phenotype resulted from the acquisition of the Δler::cat allele and the
concomitant loss of the ler+ allele. An aliquot (4 μl) of each PCR product was electrophoresed on a 1 % agarose gel and stained with ethidium
bromide prior to visualization using a transilluminator (BioRad). All (lanes 2–12), but one (lane 13), isolates had successfully replaced the wild type ler+
allele (~1.8 kb) with the mutant Δler::cat allele (~2.5 kb). Lane 1 – 1 kb TrackItTM Plus DNA Ladder; lanes 2–13 – candidate Δler::cat recombinants; lane
14 – wild type ler+ allele. b – Eviction of the cat cassette from the Δler::cat locus. Recombinants were transformed with pFT-K, a thermolabile plasmid
that expresses the FLP recombinase enzyme under the control of the TetR repressor. Varying concentration of chlorotetracycline (20–200 μg/ml) was
added to derepress the flp gene and the frequency of excisants was calculated. The excision frequency was highest at the lowest chlorotetracycline
concentration and gradually decreased with increasing chlorotetracycline concentration. Results depict the mean ± standard deviation from a
representative experiment involving two independently isolated recombinants. At least 36 candidate excisants per Δler::cat recombinant, or all
if fewer arose, were phenotyped to determine the excision frequency. c – Locus specific PCR to confirm the eviction of the cat cassette from the
Δler::cat recombinants. Excisants that were phenotypically CmS were screened by PCR using SB2456 & SB2457 to confirm that resensitization to
chloramphenicol occurred due to the loss of the cat cassette. All isolates that were phenotypically CmS (lanes 2–7) had evicted the cat cassette and
gave a PCR product of the expected size (~1.55 kb) compared to the wild type allele (lane 8; ~1.8 kb). Lane 1 – 1 kb TrackItTM Plus DNA Ladder; lanes
2–7 – candidate Δler::FRT (CmS) excisants; lane 8 – wild type ler+ allele
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E. coli, EHEC, and other phylogenetically related bacteria
exhibits a pronounced growth defect and frequently accu-
mulates suppressor mutations [101]. Moreover, the hfq
mutant is also hypersensitive to diverse stressors including
genotoxic agents [101]. It is plausible that hfq has an
analogous role in E. albertii, which may explain the low
mutational frequency at the hfq locus in the bacterium.
Conclusion
The ability to reliably and rapidly mutagenize the ge-
nomes of bacterial pathogens by recombineering has
enabled researchers to have a meticulous understanding
of the environmental and regulatory controls of viru-
lence genes, the mechanism of action of virulence fac-
tors, and the targets and traits controlled by these
virulence factors. In particular, within the last decade the
intricacies of pathogenicity accompanying A/E pathogens,
such as EPEC, EHEC, and Citrobacter rodentium have
been unraveled and their arsenal of virulence determinants
systematically characterized [14, 15, 25, 37]. This has
enabled researchers and health care providers to develop
suitable treatments to counteract these pathogens. How-
ever, the virulence regulome of the related A/E pathogen
E. albertii remains cryptic, despite accumulating evidence
that this bacterium causes disease in humans and birds
and has been classified by the CDC as an emerging patho-
gen of significant public health concern [84, 102]. To date,
not a single genome re-engineering technology has been
reported for this bacterium. This is particularly disconcert-
ing because a large-scale outbreak by E. albertii may have
catastrophic consequences and lead to significant mor-
bidity and mortality owing to our lack of understanding of
its prevalence, molecular pathogenesis, and epidemiology.
In this report we have identified a set of conditions for
successful lambda red mediated-recombineering of the
genome of E. albertii. Briefly, hyperrecombinogenicity
can be induced when the lambda red genes in pSIM6
are thermally induced at 42 °C for at least an hour prior
to making cells electrocompetent. Electrocompetent
cells are electroporated at 2.5 kV with linear dsDNA
substrate containing short terminal arms of ~50 nucleo-
tide of homology to a target gene. Electroporated cells
are recovered overnight at 37 °C/250 rpm for >16 h after
which they are plated on selective media to identify
candidate recombinants. Whereas these parameters are
suitable for reproducible recombineering in E. albertii,
however, the frequencies are ~ 4 orders of magnitude
lower than what has been reported for nonpathogenic E.
coli [28]. Moreover, consistent with previous observa-
tions in EPEC, EHEC, and E. coli [23, 25], recombination
frequency is greatly affected by the plasmid expressing
the lambda red proteins. Recombinants were readily and
reproducibly obtained when the lambda red genes were
expressed from pSIM6 but not from pKD46. The reason
for this observation is unclear. Current efforts in our lab
are dedicated towards identifying parameters for further
optimizing recombineering in E. albertii. Several factors
can influence homologous recombination. For instance,
increasing the length of the homology arms as well as
the amount of DNA can enhance recombination
frequencies [26, 52, 103]. Similarly, oligonucleotide/
ssDNA-mediated recombineering yields more recombi-
nants than dsDNA-mediated recombineering [28, 29].
Moreover, covalent modification of the 5′ end of ssDNA
with a phosphorothioate linkage has been shown to fur-
ther improve recombination in different bacterial hosts
[39]. We are in the process of evaluating some of these
parameters to potentiate lambda red mediated recombi-
neering in E. albertii.
In conclusion, our formulated protocol for recombi-
neering will enable researchers to construct a plethora of
both marked and unmarked mutations in the genome of
E. albertii. Genetic, biochemical, and phenotypic analysis
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Fig. 2 Locus specific PCR to confirm the replacement of grlRA+ with
ΔgrlRA::kan allele (a) and hfq+ with Δhfq::cat (b) in E. albertii by
recombineering. a – Three colonies were selected from LB plates
supplemented with kanamycin at 20 and at 22.5 μg/ml and screened
by PCR using the primer pair SB2470 and SB2471 to confirm that the
KanR phenotype arose from the acquisition of the ΔgrlRA::kan cassette
and the concomitant loss of the grlRA+ locus. An aliquot (4 μl) of
each PCR reaction was electrophoresed and visualized essentially as
described previously. All the KanR isolates (lanes 2–7) tested positive for
the mutant ΔgrlRA::kan allele (~2.3 kb) and negative for the wild type
allele (~1.8 kb). Lane 1 – 1 kb TrackItTM Plus DNA Ladder; Lanes 2–7 –
candidate ΔgrlRA::kan recombinants isolated on 20 μg/ml (lanes 2–4)
or 22.5 μg/ml kanamycin (lanes 5–7). Lane 8 – wild type grlRA+ allele.
b – The only colony observed on the Cm plate (6.25 μg/ml) was
verified by PCR, using the primer pair SB2485 and SB2486, to confirm
the replacement of the hfq+ allele (~527 bp) with the Δhfq::cat allele
(~1.27 kb). Lane 1–1 kb TrackItTM Plus DNA Ladder; Lanes 2–3 – replicate
PCR reactions with the solitary CmR isolate; Lanes 4–5 – replicate PCR
reactions for the wild type hfq+ allele
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of these mutants will not only shed light on the regula-
tory and signal transduction networks that govern viru-
lence gene expression but also on the structure,
function, mechanism of action, and regulon of the
encodable virulence gene products.
Methods
Bacterial Strains, Plasmids, Primers & Media
Bacteria were grown in Luria-Bertani (LB) broth supple-
mented with appropriate antibiotics when needed. The
antibiotics used were chloramphenicol (3.125–25 μg/ml),
kanamycin (12.5–25 μg/ml), chlorotetracycline (20–
200 μg/ml), and ampicillin (100 μg/ml). Strains and
plasmids used in this study are listed in Table 1
whereas oligonucleotides are listed in Table 2. The E.
coli strain DH5α was used for the propagation and
purification of plasmids.
Transformation of E. albertii with Plasmids Expressing the
Lambda Red Enzymes
E. albertii strain Albert 19982T (LMG 20976T = CCUG
46494T) was streaked onto LB plates and grown over-
night at 37 °C. The next day a single colony was inocu-
lated into 5 ml of LB and grown overnight at 37 °C/
250 rpm. The following day the overnight culture was
subcultured 100-fold into 30 ml of LB and grown to an
optical density of ~0.6–0.8. The culture was rendered
electrocompetent by multiple washes with ice-cold 10 %
glycerol and concentrated to a final volume of 400 μl.
Approximately 90 μl of the culture was electroporated
with 100 ng of the plasmid pKD46 or pSIM6. The electro-
porants were recovered in 1 ml of LB and grown for 3 h
at 30 °C, after which 200 μl of the culture was spread onto
LB plates supplemented with ampicillin (100 μg/ml) and
grown overnight at 30 °C. Two independently isolated col-
onies were picked and inoculated into 5 ml of LB supple-
mented with ampicillin and grown overnight at 30 °C/
250 rpm. These cultures were archived at −80 °C or used
for recombineering. Our initial attempts at recombineer-
ing using pKD46 were either unsuccessful or yielded very
few recombinants. However, allelic replacement was more
efficient and reproducible when the lambda red enzymes
were expressed from pSIM6. The protocol described
herein describes chromosomal manipulations in E. albertii
using pSIM6 and linear PCR products as substrates.
PCR Conditions
HiFi Taq DNA Polymerase was used for all PCR
reactions essentially as described by the manufacturer
(ThermoFisher Scientific). Typically, each PCR was per-
formed in triplicate with each replicate containing 50 μl
of the reaction mix. The cat and kan cassettes were
amplified from pKD3 and pKD13 respectively [23].
Briefly, a pair of chimeric primers was used to synthesize
the desired dsPCR product to be used in recombineer-
ing. Each primer contains two distinct regions: a 3′ re-
gion composed of ~19–20 nucleotides that hybridizes to
the template (pKD3 or pKD13) and a nonhybridizable 5′
region of ~50 nucleotides in length that is identical to
the region immediately upstream or downstream of the
Table 1 Bacterial strains and plasmids used in this study
Strain Relevant genotype, phenotype Reference/Source
LS5494 Escherichia albertii Albert 19982T Manan Sharma
LS5504 LS5494(pSIM6), AmpR (Ts) This study
LS5568 LS5494Δler::cat, CmR Clone #1 This study
LS5570 LS5494Δler::cat, CmR Clone #2 This study
LS5592 LS5568(pFT-K), CmR KanR (Ts) This study
LS5593 LS5570(pFT-K), CmR KanR (Ts) This study
LS5598 LS5494ΔgrlRA::kan, KanR This study
LS5607 LS5494Δler::FRT = LS5592Δcat ΔpFT-K, CmS KanS This study
LS5609 LS5494Δler::FRT = LS5593Δcat ΔpFT-K, CmS KanS This study
LS5612 LS5494Δhfq::cat, CmR This study
DH5α supE44 ΔlacU169 (Φ80 lacZΔM15) hsdR17 recA1 endA1 gryA96 thi-1 relA1 Bettina Bommarius
Plasmids
pSIM6 pL-gam-bet-exo genes under the control of CI857 repressor, Amp
R (Ts) Don Court
pKD46 paraBAD-gam-bet-exo under the control of AraC, Amp
R (Ts) Barry Wanner
pKD3 Template plasmid to amplify FRT-cat-FRT amplicon, AmpR CmR Barry Wanner
pKD13 Template plasmid to amplify FRT-kan-FRT amplicon, AmpR KanR Barry Wanner
pFT-K flp gene under the control of TetR repressor, KanR (Ts) Fred Blattner
Tet – Tetracycline, Cm – chloramphenicol, Amp – ampicillin, Kan – Kanamycin, superscripts “R” and “S” denote resistance and sensitivity respectively
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locus to be mutated. The PCR reaction yields an amplicon
consisting of an FRT-cat/kan-FRT cassette that is flanked
by two homology arms, each of which is 50 nucleotides in
length. A double crossover event between the homology
arms and their complementary sequences on the chromo-
some results in allelic replacement. The conditions for
PCR were as follows: [Step 1: 94 °C/5′; Step 2: 94 °C/0.5′;
Step 3: 43 °C/0.5′; Step 4: 68 °C/2′; Step 5: Repeat steps
2–4 [x40 cycles]; Step 6: 72 °C/7′; Step 7: 15 °C for ∞].
The synthesis of each amplicon was verified by gel elec-
trophoresis and the PCR product was concentrated using
the DNA Clean & Concentrator Kit™-25 from Zymo
Research (D4005) into a final volume of 25 μl of elution
buffer (10 mM Tris–HCl [pH 8.5], 0.1 mM EDTA). The
eluted PCR product was further concentrated by ethanol
precipitation. Briefly, 2 μl of glycogen (20 mg/ml), 20 μl of
sodium acetate (pH 5.2), and 900 μl of cold 100 % ethanol
(−20 °C) were added to the eluted PCR product and thor-
oughly mixed. The sample was stored at −20 °C for at least
30′ after which it was centrifuged at 4 °C/16000 rpm for
15′. The supernatant was discarded and the pellet washed
with 500 μl of 70 % ethanol followed by centrifugation at
4 °C/16000 rpm for 5′ (3x). After the last centrifugation
step all the ethanol was vaporized and the sedimented pel-
let was resuspended in 10 μl of molecular grade water.
Preparation of Electrocompetent Cells for
Recombineering
E. albertii(pSIM6) transformants were streak purified
onto pre-warmed LB + Amp100 and incubated overnight
at 30 °C to obtain axenic colonies. A single colony was
inoculated into 5 ml of LB + Amp100 and incubated ON
at 30 °C/250 rpm. The overnight culture was diluted 100
fold in 30 ml of LB + Amp100 and grown at 30 °C/
250 rpm in an incubator-shaker to an OD600 of 0.6–1.0.
The cultures were then heat shocked at 42 °C/250 rpm
for 1 h in a water bath to induce the expression of the
lambda red exo, bet, and gam genes from pSIM6. The
pSIM family of plasmids was engineered in the lab of
Don Court at the National Institutes of Health (NIH)
[28]. Note that we, and other researchers, have observed
that recombineering is more efficient when the cultures
are thermally induced in a water-shaker as opposed to
an air-shaker (data not shown). After induction the cul-
tures were rapidly chilled by swirling in an ice-water
bath for ~2′ and then transferred to pre-chilled 50 ml
conical tubes. The cultures were then centrifuged at
4100 rpm/4 °C/10′. Subsequently, the supernatant was
discarded and each pellet was initially resuspended in
1 ml of ice-cold 10 % glycerol after which the volume
was increased to 30 ml by the addition of 29 ml of ice-
cold 10 % glycerol. The centrifugation step was repeated
and the supernatant discarded. This was followed by
suspending the pellet in 1 ml of ice-cold 10 % glycerol
and transferring the suspension to a pre-chilled micro-
centrifuge tube. The tubes were centrifuged at
10,000 rpm/4 °C/2′ and the supernatant discarded. The
washes with ice-cold 10 % glycerol were repeated a
minimum of 3 times. After the last wash the pellet was
resuspended in 400 μl of ice-cold 10 % glycerol.
Approximately 90 μl of electrocompetent cells were ali-
quoted into microcentrifuge tubes and 1.5 μg of the
ethanol precipitated PCR product was added to the
chilled culture. For the negative control no PCR product
was added. The mixture was incubated on ice for ~ 1′
after which it was transferred to a pre-chilled cuvette
and electroporation was performed at a voltage of ~1.8–
2.5 kV. Immediately after electroporation the cells were
recovered in 1 ml of LB and then transferred to a test
tube containing 9 ml of LB. The recoverants were
Table 2 Oligonucleotides used in this study
Primers Purpose Sequence
SB2454 5′ primer for replacing ler with cat GATTAGGTCATTAATAGCTTAATATATTAAAGCATGCGGAGATTATTTATcatatgaatatcctcctta
SB2455 3′ primer for replacing ler with cat TATCGTTATCATCTAATGGTTTTATATTAAATATTTTTCAGCGGCATTAAgtgtaggctggagctgcttc
SB2456 5′ primer to verify ler deletion gcgGAATTCCCTTTAGCTCCTGGCACTTTTGAAC
SB2457 3′ primer to verify ler deletion gcgAAGCTTTGACGTAATATTTTATTCAGCTGAT
SB2464 5′ primer for replacing grlRA with kan TGGATAGAACAAATTGAAAGGAGTGAGGTTGGTATGAAACTGAGTGAGTTgtgtaggctggagctgcttc
SB2467 3′ primer for replacing grlRA with kan ATGTATGTGAAAAGTTATGTCTAACTCCCTTTTTTCCGTCTCATGATCATttccggggatccgtcgacct
SB2470 5′ primer to verify grlRA deletion gcgGAATTCTGAGCCTGTGGCACAATTGAT
SB2471 3′ primer to verify grlRA deletion gcgAAGCTTGCAGTCTGATGAAGTGATCCC
SB2481 5′ primer for replacing hfq with cat TCAGAATCGAAAGGTTCAAAGTACAAATAAGCATATAAGGAAAAGAGAGAcatatgaatatcctcctta
SB2482 3′ primer for replacing hfq with cat AAAAACAGCCCGAAACCTTATTCGGTTTCTTCGCTGTCCTGTTGCGCGGAgtgtaggctggagctgcttc
SB2485 5′ primer to verify hfq deletion gcgGAATTCGCTATCGCAGGCTGAATGTGT
SB2486 3′ primer to verify hfq deletion gcgAAGCTTACCAGCATCATAACGGTCAAA
Uppercase unbolded letters = oligonucleotide sequence homologous to the bacterial chromosome; lowercase letters = sequence complementary to the template
pKD3 (for cat) or pKD13 (for kan); Uppercase bolded letters = Restriction sites; lowercase italicized letters – trinucleotide sequence flanking restriction sites
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incubated at 37 °C/250 rpm for at least 16 h. The next
day 1.5 ml of the overnight grown culture was trans-
ferred to microcentrifuge tubes and pelleted by centrifu-
gation at 16000 rpm/2′. The supernatant was discarded
and the pellet resuspended in ~150–200 μl of LB broth,
after which, the cell suspension was plated on LB plates
supplemented with chloramphenicol (3.125–25 μg/ml)
or kanamycin (15–22.5 μg/ml). The plates were incu-
bated at 37 °C for ~1–2 days until recombinants were
observed. Once recombinants arose then individual col-
onies were inoculated into 50 μl of LB and incubated for
~3 h at 37 °C. Locus-specific PCR was performed on
2 μl of the culture to verify the replacement of the
chromosomal allele with the mutant allele.
Curing of pSIM6
Once recombinants had been identified then ~2 μl of
the culture was streaked onto LB+ Cm6.25/Kan22.5 plates
and incubated overnight at 42 °C. The next day a few
colonies were picked from each sector and patch plated
onto LB + Cm/Kan and LB + Amp plates and incubated
overnight at 30 °C. The vast majority of the CmR or
KanR recombinants were phenotypically AmpS suggest-
ing that the resident plasmid pSIM6 had been cured
from the recombinants.
Eviction of the Drug Resistance Cassette
To evict the cat cassette, the recombinants were trans-
formed with the plasmid pFT-K [104]. Transformation
was done essentially as described above. pFT-K is a
thermolabile replicon that confers temperature-sensitive
resistance to kanamycin (25 μg/ml) and expresses the flp
recombinase under the control of the tetracycline re-
pressor (TetR) of the transposon Tn10. All the KanR
transformants that were observed were pooled together
into 20 ml of LB supplemented with kanamycin and
grown overnight at 30 °C/250 rpm. The overnight grown
culture was diluted 100 fold into fresh identical media
and incubated at 30 °C under static conditions for 24 h.
The following day the FLP recombinase was induced by
diluting the overnight culture 4 fold in 20 ml of LB sup-
plemented with unautoclaved chlorotetracycline, at a
range of concentrations (20–200 μg/ml), and growing
overnight at 30 °C under static conditions. Chlorotetra-
cycline binds to and inactivates the TetR repressor
thereby derepressing the flp gene. FLP recombinase, in
turn, recognizes and catalyzes the site-specific recombin-
ation between the two direct repetitive FRT sites to evict
the bracketed cat resistance cassette, leaving behind a
solitary residual FRT site. As a consequence, the engi-
neered bacterial excisant becomes resensitized to chlor-
amphenicol. After overnight induction of the cultures, a
loopful of bacteria was streaked onto nonselective LB
plates and incubated overnight at 42 °C to cure the
thermolabile plasmid. The next day ~36 independently
isolated colonies were spot-streaked onto LB, LB + Cm,
and LB + Kan and incubated overnight at 30 °C to screen
for the CmS excisants that had also been cured of the
plasmid (KanS). If the excisant had not been cured of the
plasmid then the CmS isolate was re-streaked onto fresh
LB plates and incubated for another night at 42 °C to
cure the plasmid. The genotype of the excisants was fur-
ther verified by PCR as described above.
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